Consequences of not listening to the patients in clinical trials
Are you overlooking patient feedback on your investigational drug? Interestingly, the pharmaceutical industry is one of the few industries where...
Patient preferences as input to medical product decision making
PREFER’s patient input to decision making under evaluation by EMA and EUnetHTA. At Clinigma®, we are always happy to follow the development of projects promoting patient engagement...
Have you considered improving the feedback from investigators and study nurses in your clinical trials?
The importance of interviewing investigators and study nurses. Not only is it relevant to interview the patients participating in clinical trials – it can also be highly valuable to…
The benefits of interviewing patients when developing orphan drugs
Screening and exit interviews are particularly beneficial to inform the development of drugs for rare diseases. Patient interviews can be helpful to obtain direct patient feedback regarding…
Can you set a strong outcomes strategy without listening to the patients?
Interviewing patients can help you in choosing the most relevant patient-reported outcome measures to apply in your clinical trials. Patient-reported outcome measures (PROMs) are frequently applied…
Can you set a strong marketing strategy without hearing what users think about your investigational drug?
Get a clearer picture of your investigational drug prior to market launch. Interestingly, the pharmaceutical industry has remained one of the few industries where direct user feedback is not…